drugset / Trial / NCT06949020

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

NCT06949020

Phase 2 Not yet recruiting 160 enrolled Jemincare
RandomizedParallel-groupTriple-blindTreatment

Summary

To Evaluate the Safety, Efficacy, and Pharmacokinetic/Pharmacodynamics Characteristics of JMKX003142 injection Administered Randomly,Double-blind, Placebo-controlled Study in Chinese Cardiacl Edema Patients.

Timeline

Start
2025-06-01
Primary completion
2027-01-31
Completion
2027-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject JMKX003142 Unknown

Indications